Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

1.6K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.6K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

6.3K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
6.3K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

1.4K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.4K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.5K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.5K
Dialysis01:27

Dialysis

2.0K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.0K
Dialysis01:15

Dialysis

2.2K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease.

Nephron·2026
Same author

Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol.

Drugs·2026
Same author

The Impact of Glomerular Disease on Dyslipidemia in Pediatric Patients Treated with Dialysis.

Nutrients·2025
Same author

Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study.

Lancet regional health. Americas·2024
Same author

Hyperkalemia Recurrence and Its Association With Race and Ethnicity in United States Veterans: A Retrospective Cohort Study.

Cureus·2024
Same author

Individualized Risk of CKD Progression among US Adults.

Journal of the American Society of Nephrology : JASN·2024

Related Experiment Video

Updated: Mar 31, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K

Peritoneal Equilibration Test and Patient Outcomes.

Rajnish Mehrotra1, Vanessa Ravel2, Elani Streja2

  • 1Kidney Research Institute, University of Washington, Seattle, Washington; rmehrotr@uw.edu.

Clinical Journal of the American Society of Nephrology : CJASN
|October 15, 2015
PubMed
Summary

Dialysate/plasma creatinine is a reliable predictor of mortality and hospitalization in peritoneal dialysis patients. Other peritoneal equilibration test parameters did not improve risk prediction beyond this established measure.

Keywords:
creatininedialysis solutionsfollow-up studieshospitalizationhumansmortalityperitoneal dialysisrenal dialysisultrafiltration

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.9K

Related Experiment Videos

Last Updated: Mar 31, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.9K

Area of Science:

  • Nephrology
  • Clinical Chemistry
  • Dialysis

Background:

  • The peritoneal equilibration test (PET) provides three key parameters: dialysate/plasma creatinine, dialysate glucose, and ultrafiltration volume.
  • Current research predominantly focuses on dialysate/plasma creatinine for predicting outcomes in peritoneal dialysis (PD).
  • The prognostic value of dialysate glucose and ultrafiltration volume for daily ultrafiltration and patient outcomes remains underexplored.

Purpose of the Study:

  • To investigate the predictive capabilities of different PET parameters for patient outcomes.
  • To determine if dialysate glucose and ultrafiltration volume offer superior risk prediction compared to dialysate/plasma creatinine.
  • To validate the prognostic value of dialysate/plasma creatinine in a large, contemporary PD cohort.

Main Methods:

  • Analysis of data from 10,142 PD patients across 764 US dialysis facilities (2007-2011).
  • Median follow-up of 15.8 months, with 87% on automated peritoneal dialysis (APD).
  • Examined associations between PET parameters (creatinine, glucose, ultrafiltration) and all-cause mortality, technique failure, and hospitalization rates.

Main Results:

  • Dialysate/plasma creatinine showed a linear association with mortality and hospitalization rates.
  • Dialysate/plasma creatinine and dialysate glucose demonstrated similar risk prediction capabilities (highly correlated, r=-0.84).
  • Ultrafiltration volume was inversely related to hospitalization but not mortality; no parameters predicted technique failure. Adding other parameters did not enhance prediction by dialysate/plasma creatinine alone.

Conclusions:

  • Dialysate/plasma creatinine is confirmed as a robust predictor of outcomes in PD patients.
  • The study validates the established role of dialysate/plasma creatinine in risk stratification for peritoneal dialysis.
  • Alternative PET parameters did not demonstrate superior predictive value in this large cohort.